Literature DB >> 30113854

Prevalence, Awareness, Treatment, Control, and Correlates of Hypertension in the Pars Cohort Study.

Abdullah Gandomkar1, Hossein Poustchi2,3, Fatemeh Malekzadeh1,2,3, Masoud M Malekzadeh2,3, Maryam Moini4, Mohsen Moghadami1, Hadi Imanieh1, Mohammad Reza Fattahi4, Mohammad Mahdi Sagheb5, Seyyed Mohammad Taghi Ayatollahi6, Sadaf G Sepanlou2,3, Reza Malekzadeh1,2,3.   

Abstract

BACKGROUND: High blood pressure is an important risk factor for all-cause mortality and cardiovascular mortality and morbidity among Iranians. We aimed to estimate its prevalence, correlates, and its rate of awareness, treatment, and control in South of Iran.
METHODS: The Pars Cohort Study (PCS) was launched in a district of Fars province. All residents between 40 and 75 years old in the district were recruited from 2012 to 2014. Hypertension was defined as either systolic/diastolic blood pressure ≥ 140/90 mm Hg or taking medications. Logistic regression was used to identify the correlates of hypertension and awareness and its treatment and control. A total of 9264 participants were recruited. Of the total participants, 46.2% were men. The mean age was 52.6 years (SD: 9.7).
RESULTS: Prevalence of hypertension was 26.9%. Of the total 2489 hypertensives, 49.6% were aware and 55.7% were under treatment. Blood pressure was controlled in 69.2% of treated hypertensives. In the adjusted model, female sex and history of cardiovascular disease (CVD) were positively associated with having hypertension, higher awareness, and better treatment and control. Older age, being overweight or obese, and having a history of diabetes were also positively associated with having hypertension and higher awareness and treatment; however, being overweight or obese was associated with poorer hypertension control. Older age and having a history of diabetes did not show a statistically significant association with control.
CONCLUSION: Being underweight and higher physical activity were inversely associated with having hypertension but were not associated with awareness, treatment, or control. Prevalence of hypertension is high but the rates of awareness, treatment, and control are not adequate.
© 2018 The Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Entities:  

Keywords:  Awareness; Blood pressure; Hypertension; Iran; Prevalence; Risk factor

Mesh:

Substances:

Year:  2018        PMID: 30113854

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  7 in total

1.  Hypertension and Pre-Hypertension Among Iranian Adults Population: a Meta-Analysis of Prevalence, Awareness, Treatment, and Control.

Authors:  Roghaiyeh Afsargharehbagh; Khadije Rezaie-Keikhaie; Hosien Rafiemanesh; Abbas Balouchi; Salehoddin Bouya; Behroz Dehghan
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

2.  Prevalence, Awareness, Treatment, and Control of Hypertension among Adult Residents of Tehran: The Tehran Cohort Study.

Authors:  Alireza Oraii; Akbar Shafiee; Arash Jalali; Farshid Alaeddini; Soheil Saadat; Saeed Sadeghian; Hamidreza Poorhosseini; Mohamamdali Boroumand; Abbasali Karimi; Oscar H Franco
Journal:  Glob Heart       Date:  2022-05-11

3.  The prevalence and predictors of pre-hypertension and hypertension in Kherameh cohort study: a population based study on 10,663 persons in south of Iran.

Authors:  Abbas Rezaianzadeh; Fatemeh Jafari; Seyed Ebrahim Sadeghi; Salar Rahimikazerooni
Journal:  J Hum Hypertens       Date:  2020-03-17       Impact factor: 3.012

4.  Prevalence, awareness, treatment, and control of hypertension and their determinants: Results from the first cohort of non-communicable diseases in a Kurdish settlement.

Authors:  Fatemeh Rajati; Behrooz Hamzeh; Yahya Pasdar; Roya Safari; Mehdi Moradinazar; Ebrahim Shakiba; Shahrzad Bazargan-Hejazi; Hossein Karim; Farid Najafi
Journal:  Sci Rep       Date:  2019-08-27       Impact factor: 4.379

5.  Prevalence and Predicting Risk Factors of Polypharmacy in Azar Cohort Population.

Authors:  Afshin Gharekhani; Mohammadhossein Somi; Alireza Ostadrahimi; Ayda Hatefi; Arash Haji Kamanaj; Sina Hassannezhad; Elnaz Faramarzi
Journal:  Iran J Pharm Res       Date:  2022-05-08       Impact factor: 1.962

6.  Awareness, treatment, and control of hypertension and related factors in adult Iranian population.

Authors:  Mohsen Mirzaei; Masoud Mirzaei; Behnam Bagheri; Ali Dehghani
Journal:  BMC Public Health       Date:  2020-05-12       Impact factor: 3.295

7.  Prevalence of Cardiovascular Disease Risk Factors in the Women Population Covered by Health Centers in Ardabil.

Authors:  Leli Avesta; Sina Rasoolzadeh; Mahdi Naeim; Aziz Kamran
Journal:  Int J Hypertens       Date:  2022-02-27       Impact factor: 2.420

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.